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ABSTRACT Recent research has demonstrated that selection for antibiotic resis-
tance occurs at very low antibiotic concentrations in single-species experiments, but
the relevance of these ﬁndings when species are embedded in complex microbial
communities is unclear. We show that the strength of selection for naturally occur-
ring resistance alleles in a complex community remains constant from low subinhibi-
tory to above clinically relevant concentrations. Selection increases with antibiotic
concentration before reaching a plateau where selection remains constant over a
2-order-magnitude concentration range. This is likely to be due to cross protection
of the susceptible bacteria in the community following rapid extracellular antibiotic
degradation by the resistant population, shown experimentally through a combina-
tion of chemical quantiﬁcation and bacterial growth experiments. Metagenome and
16S rRNA analyses of sewage-derived bacterial communities evolved under cefo-
taxime exposure show preferential enrichment for blaCTX-M genes over all other
beta-lactamase genes, as well as positive selection and co-selection for antibiotic re-
sistant, opportunistic pathogens. These ﬁndings have far-reaching implications for
our understanding of the evolution of antibiotic resistance, by challenging the long-
standing assumption that selection occurs in a dose-dependent manner.
IMPORTANCE Antibiotic resistance is one of the greatest global issues facing soci-
ety. Still, comparatively little is known about selection for resistance at very low anti-
biotic concentrations. We show that the strength of selection for clinically important
resistance genes within a complex bacterial community can remain constant across
a large antibiotic concentration range (wide selective space). Therefore, largely un-
derstudied ecological compartments could be just as important as clinical environ-
ments for selection of antibiotic resistance.
KEYWORDS antibiotic resistance, evolution, metagenomics, microbial ecology
Antibiotic resistance poses a major threat to society, the sustainability of modernhealth care systems, food security, and the global economy (1, 2). Until recently,
most research on evolution of resistance focused on selection at clinically relevant
antibiotic concentrations, as the “traditional” selective window hypothesis was univer-
sally accepted. This hypothesis states that selection for antibiotic resistance will occur
only above the MIC of susceptible bacteria and below the MIC of resistant bacteria (3).
In fact, numerous experimental studies have observed selection for resistance at
sub-MIC antibiotic concentrations, at the point where the selective pressure (antibiotic)
is sufﬁcient to offset the cost of resistance (3–7). In recent isogenic studies, a single host
species with chromosomal or plasmid-borne resistance mechanisms was competed
with its susceptible counterpart at various concentrations of antibiotic to determine the
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minimal selective concentration (MSC) (3, 5). The MSC is the lowest concentration of
antibiotic at which resistance is positively selected, which can be signiﬁcantly lower
than the MIC (3, 5). MSCs have also been estimated using publicly available, clinical
breakpoint data (8), but experimental data are required to assess the validity of these
predictions, especially in a community context. These ﬁndings show that the selec-
tive compartment (the antibiotic gradient and spatial range along which resistant
bacteria/genes could be enriched) is much larger than previously thought (9). This in
turn suggests that selection may be occurring in previously unconsidered selective
compartments which harbor relatively low antibiotic concentrations, such as the gut
microbiome, wastewater, and even surface waters contaminated with antibiotic resi-
dues.
Though these ﬁndings are signiﬁcant, the use of single species means that their
relevance with regard to selection in complex microbial communities remains unclear.
Many studies have quantiﬁed numbers and/or prevalence of resistance genes in
wastewater inﬂuent and efﬂuent (including, but not limited to, references 10 and 11),
with a recent study utilizing emulsion, paired isolation, and concatenation PCR
(epicPCR) to identify the host background of highly abundant resistance genes (12).
However, positive selection for resistance within complex bacterial communities is a
current knowledge gap (13), with experimental MSC data in complex communities
severely lacking. One recent study (14) reported a biological effect at low concentra-
tions of tetracycline in a microbial community, by quantifying tetracycline resistance
gene prevalence (tetA and tetG genes normalized to 16S rRNA copy number). However,
as starting gene frequencies were not measured, it is unclear if the observed effect was
driven by positive selection or reduced negative selection. In other words, without
comparing the ﬁnal resistance gene prevalence to the initial resistance gene preva-
lence, it is unknown if resistance genes actually increased over time under tetracycline
exposure (i.e., were positively selected) or if resistance genes were simply lost at a lower
rate than the no-antibiotic control (i.e., were negatively selected or showed increased
persistence). Here, we aimed to quantify positive selection in a complex bacterial
community by conducting evolution experiments using a wastewater bacterial com-
munity inoculum to determine the MSC of cefotaxime. Co-selection for other resistance
genes and effects on community structure were also determined through metagenome
analyses.
Cefotaxime is a World Health Organization (WHO) recognized “critically important”
antibiotic (15) “essential” for human medicine (16) that was most recently identiﬁed as
a key antimicrobial stewardship target through inclusion in the WHO “watch list” of
essential medicines (17). In this study, the prevalence of the blaCTX-M gene group was
determined with quantitative PCR (qPCR) and selection coefﬁcients were calculated to
estimate the MSC of cefotaxime. CTX-Ms are extended-spectrum beta-lactamases
(ESBLs) which cleave the beta-lactam ring, effectively inactivating and degrading
beta-lactam antibiotics (18). Previous work has demonstrated that beta-lactamases can
inactivate extracellular beta-lactams, to the beneﬁt of nearby susceptible bacteria
(19–21). This protective effect on susceptible bacteria has since been shown for an
intracellularly expressed resistance mechanism, also degradative in nature (22).
Results show, for the ﬁrst time, that selection for blaCTX-M genes occurs at very low,
subinhibitory concentrations. We also demonstrate that selection occurs with equal
potency at very low antibiotic concentrations and at concentrations greatly exceeding
those used in the clinic. Therefore, antibiotic resistance is not always selected for in a
dose-dependent manner. These ﬁndings illustrate the importance of studying selec-
tion for resistance within complex bacterial communities over a wide selective range,
representative of different selective compartments (9).
RESULTS
Cefotaxime exposure affects community structure. Complex community (raw,
untreated wastewater) microcosms were spiked with a range of cefotaxime concentra-
tions. The exposure concentration range was selected from the EUCAST (23) deﬁned
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clinical breakpoint concentration (the concentration at which Enterobacteriaceae are
considered “clinically” resistant) down to 0, in a 2-fold dilution series including con-
centrations similar to those previously measured in different environments (such as
hospital efﬂuent, wastewater treatment plant efﬂuent, and surface waters [few micro-
grams/liter up to 150 g/liter {24–26}]). Bacterial communities were transferred daily
into fresh medium and fresh antibiotic for 8 days. Chemical quantiﬁcation was per-
formed at the beginning of day 0 and after 24 h, to determine an accurate MSC (based
on measured rather than nominal antibiotic concentration) and to assess the chemical
stability of cefotaxime (a third-generation cephalosporin of the beta-lactam class of
antibiotics) in the system.
At the end of the experiment, three replicates from a low, medium, and high
antibiotic concentration were selected to undergo metagenome analyses alongside the
unexposed control to identify the key resistance genes under selection. Metagenome
DNA was sequenced with an Illumina MiSeq2 sequencer.
16S rRNA data were extracted from trimmed, quality-controlled paired reads with
MetaPhlAn2 (27). Overall, the community comprised predominantly Gram-negative
bacteria, though Gram-positive bacteria were also detected (see Fig. S1 in the supple-
mental material). Between-sample variation was expected due to unavoidable hetero-
geneity within the complex community inoculum. Even so, there were clear differences
between the control untreated bacterial community and the communities exposed to
cefotaxime among the 25 most abundant species (Fig. 1; all detected species can be
seen in Fig. S1). In particular, several species were eliminated by cefotaxime treatment
(or reduced below the limit of detection). These included the opportunistic Gram-
negative pathogens Providencia alcalifaciens, Aeromonas veronii, Morganella morganii,
and Klebsiella pneumoniae, as well as the opportunistic Gram-positive pathogen Strep-
tococcus infantarius. All of these were signiﬁcantly associated with the no-antibiotic
FIG 1 Heat map showing the relative abundance of detected species using Bray-Curtis distance measure-
ments for treatment (x axis) and species (y axis) for each cefotaxime treatment. “C0,” “C4,” “C6,” and “C8”
correspond to 0, 125, and 500 g/liter and 2 mg/liter cefotaxime, respectively. The number after the
concentration denotes the biological replicate number (1 to 5), chosen randomly for sequencing at day 8
of the experiment.
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control as determined by linear discriminant analysis (LDA) effect size (LEfSe) analyses
(Fig. S2). Conversely, several Gram-negative and Gram-positive opportunistic patho-
gens showed greater abundance in treated communities than in the untreated control,
namely, Pseudomonas aeruginosa, Acinetobacter baumannii, Bacteroides fragilis, and
Enterococcus faecalis; however, only P. aeruginosa was signiﬁcantly enriched in the 2
mg/liter cefotaxime treatment (LEfSe, Fig. S2). Cefotaxime treatment also resulted in
slightly decreased numbers of Escherichia coli, though this was not signiﬁcant and it
was still the predominant species across all treatments. In general, there was much
greater variability between treatment replicates compared to the untreated control
(Fig. S1).
blaCTX-M genes are preferentially selected over all other beta-lactam resistance
mechanisms. Metagenome data were further analyzed with the ARGs-OAP pipeline
(28), designed to thoroughly interrogate metagenome data and identify resistance
genes. Selection for beta-lactam resistance was prominent (as expected); however,
co-selection for resistance to unrelated antibiotic classes was also observed, namely,
co-selection for resistance to macrolides, aminoglycosides, trimethoprim, tetracyclines,
and sulfonamides, which is likely to be due to carriage of multiresistance plasmids (see
Fig. S3).
We delved deeper into the beta-lactam resistance genes to determine which genes,
if any, were preferentially selected. We observed substantial enrichment for the beta-
lactamase and extended-spectrum beta-lactamase (ESBL) genes blaTEM, blaOXA, and
blaCTX-M (Fig. 2). Average increases in relative abundance from the lowest to highest
concentration were 8-fold, 8-fold, and 70-fold, respectively. blaCTX-M was preferentially
selected over all other beta-lactamase-encoding genes at each cefotaxime concentra-
tion.
The MSC of cefotaxime is very low, but selection plateaus across a large
concentration range. Given the strong positive selection for blaCTX-M, we focused on
accurate quantiﬁcation of this group of genes across the entire experimental antibiotic
gradient using qPCR. This follows previous work which showed that qPCR is the most
sensitive method for MSC determination (14). blaCTX-M gene copy number was normal-
ized to 16S rRNA copy number, to determine a molecular prevalence of blaCTX-M; this
FIG 2 Heat map showing average (n  3) detected beta-lactam resistance gene subtype relative abundance (resistance gene number
normalized with 16S rRNA copy number), following 8 days of culture with cefotaxime. Only genes detected with the ARGs-OAP pipeline
are shown.
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prevalence was determined for each cefotaxime concentration at both the beginning
and end of the experiment. A Kruskal-Wallis test conﬁrmed that blaCTX-M prevalence,
16S rRNA copy number, and blaCTX-M copy number (all n  5 each) did not differ
signiﬁcantly between treatments at day 0.
Selection coefﬁcients based on change in blaCTX-M prevalence over time were
calculated and plotted against cefotaxime concentration as in previous single-species
assays (3, 5) (Fig. 3). A positive selection coefﬁcient value indicates that positive
selection is occurring, and the x axis intercept estimates the MSC, here 0.4 g/liter
(Fig. S4).
blaCTX-M prevalence increased over time (Fig. S5) and with antibiotic concentration
(linear term: F1, 42 26.3, P 0.001) but appeared to plateau at 500 g/liter (quadratic
term: F1, 42  13.2, P  0.001), and so an additional experiment was performed to
determine if this plateau continued at higher concentrations (Fig. 3). As hypothesized,
blaCTX-M prevalence increased when exposed to cefotaxime (linear term: F1, 36  9.6,
P  0.01) but remained relatively constant (quadratic term: F1, 36  9.4, P  0.01) up
until the two highest concentrations used in this study (Fig. 3). These concentrations
are over 30 times and 50 times the deﬁned clinical breakpoint cefotaxime concentra-
tion of 2 mg/liter for Enterobacteriaceae. The rise in blaCTX-M prevalence at 64 mg/liter
was due to an increase in blaCTX-M gene copy number, and the decrease at 128 mg/liter
was due to a signiﬁcant decrease in blaCTX-M and slight reduction in 16S rRNA copy
number (Fig. S6 and S7).
The bacterial community readily degrades cefotaxime. We hypothesized that
this plateau in selection was due to both the mechanism and sociality of the blaCTX-M
genes: as beta-lactamase enzymes can be found both intracellularly and extracellularly
(21), the plateau in blaCTX-M prevalence may be due to negative frequency-dependent
selection (19). In other words, the more prevalent blaCTX-M becomes, the lower its
ﬁtness as cefotaxime degradation is accelerated to the beneﬁt of the entire community,
including non-blaCTX-M-bearing competitors. To investigate if cefotaxime was de-
graded by the community, chemical quantiﬁcation of cefotaxime in the presence of the
community was performed. Incubating the microcosms for 24 h resulted in complete
degradation of cefotaxime, at all but the highest concentration (Table S1). All measured
concentrations were lower than expected, and the lowest concentration (15.625 g/
liter) was below the limit of detection at the beginning of the assay. Therefore, the MSC
(0.4 g/liter) is estimated based on nominal concentrations but in reality is likely to be
lower still. As cefotaxime is known to be relatively unstable (29), an overnight degra-
dation experiment was conducted to determine the amount of biotic and abiotic
FIG 3 Selection coefﬁcients (n  5) for each cefotaxime concentration, which equal the natural log of
resistance gene prevalence (blaCTX-M gene/16S rRNA copy number) at day 0 and day 8. Circles, selection
coefﬁcients from low-concentration experiment; squares, selection coefﬁcients from high-concentration
experiment. Selection coefﬁcients of 0 indicate positive selection.
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degradation occurring in the experimental system. A sterile microcosm and another
inoculated with the complex community were incubated and destructively sampled at
0 h, 6 h, and then every 3 h for 24 h. In sterile culture, cefotaxime had only partially
degraded over 24 h, whereas in the presence of the community, cefotaxime was
undetectable following 12 h of incubation (Fig. 4). This increase in degradation rate
coincided with the beginning of the exponential growth phase of the community
(Fig. S8).
Extracellular beta-lactamases “protect” susceptible bacteria at cefotaxime con-
centrations well above the MIC. To conﬁrm that this degradation was biotic and by
extracellular beta-lactamases, an additional experiment was performed whereby a
susceptible E. coli strain (J53) was cultured in the presence of supernatant derived from
an overnight culture of an E. coli strain bearing blaCTX-M-15, blaTEM-1, and blaOXA-1 on a
fully sequenced resistance plasmid (30) (strain NCTC 13451, available from Public
Health England). Addition of the supernatant from the resistant strain allowed growth
of the susceptible strain at the clinical breakpoint concentration (23), which was over
10 times the MIC of the susceptible strain (Fig. 5).
DISCUSSION
Here, we quantiﬁed positive selection for antibiotic (cefotaxime) resistance in a
wastewater-derived complex bacterial community, by quantifying changes in resis-
tance gene prevalence over time. We show that clinically important (31) resistance
genes (blaCTX-M) were positively selected at very low, environmentally relevant con-
centrations likely due to a combination of clonal expansion of hosts carrying blaCTX-M
and horizontal gene transfer of plasmids bearing bla-CTX-M. Antibiotic quantiﬁcation has
been identiﬁed as an overlooked aspect of MSC determination (13). We quantiﬁed
FIG 4 Single biological replicate and duplicate chemical replicate quantiﬁcation of cefotaxime (measured cefotaxime concentration g/liter) at
0 and 6 h and then every 3 h for 24 h at different starting cefotaxime concentrations (micrograms/liter) in the presence of the complex bacterial
community and in sterile culture.
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antibiotic concentrations when determining the MSC and found cefotaxime to be
rapidly degraded by the community, suggesting the estimated MSC of 0.4 g/liter to
be an underestimate. Even so, the cefotaxime MSC determined in this study was very
similar to several measured environmental concentrations (25, 32), suggesting that
selection could occur in certain environments such as hospital efﬂuent and wastewater
inﬂuent. Responses to selection in such environments may be reduced, as unenriched
bacterial communities, e.g., in sewage, may be impacted by high cell numbers and
associated reduction in resource availability. However, it is also possible that sustained
exposure over long periods would produce the same response.
In addition, we observed a plateau in the strength of selection across a very large
antibiotic concentration range. This novel ﬁnding contrasts with previous work which
has shown resistance to increase monotonically with antibiotic concentration (3, 5, 14).
A crucial implication of this ﬁnding is that selection for clinically important resistance
mechanisms, such as blaCTX-M, may occur to a similar extent at subinhibitory concen-
trations as at high, clinical concentrations. The observed plateau in resistance selection
has clinical relevance, when considering the antibiotic concentration gradients which
inevitably form in different body compartments during chemotherapy (33). These may
also provide greater potential for selection for antibiotic resistance in vivo than previ-
ously considered. Potential overtreatment with unnecessarily long antibiotic courses
(34) may compound this effect. Future research should address this ﬁnding and its
relevance to environmental protection, effective antibiotic treatment, and antimicrobial
stewardship.
The observed plateau in selection for resistance is likely due to the cross-protective
effect conferred by the resistant fraction on the susceptible fraction of bacteria in the
population. Three lines of evidence strongly support this: (i) the degradative effect of
the community, whereby within 24 h all cefotaxime is degraded below the limit of
chemical quantiﬁcation, including the very highest, clinical breakpoint concentration;
(ii) metagenome analyses of 3 replicates at 4 antibiotic concentrations, which showed
that the main mechanism of resistance to the treatment antibiotic was degradative in
nature and could therefore provide a beneﬁt to susceptible competitors within the
community; (iii) the single-species E. coli experiment, which used supernatant from a
resistant strain bearing a multiresistance plasmid with the plasmid-free strain to show
the potential extent of this community-wide beneﬁt. The level of protection conferred
by extracellular beta-lactamases in the supernatant of the resistant strain culture
allowed growth of the susceptible strain well above its own MIC, at the clinical
FIG 5 Average (n  4) optical density (600 nm) over time of susceptible E. coli strain J53 grown in 2
mg/liter cefotaxime (clinical breakpoint concentration for Enterobacteriaceae) with beta-lactamase-
containing supernatant (NCTC strain 13451) or beta-lactamase-free supernatant (strain J53).
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breakpoint concentration. Extrapolating this ﬁnding to the community, we hypothesize
that within each 24 h period, CTX-M producers (and possibly other degraders) are
selected for by cefotaxime and are then outcompeted by susceptible bacteria following
antibiotic degradation. This means that resistant genotypes are likely to persist at even
very low antibiotic concentrations, as they provide a beneﬁt to the whole community;
this effect has been modeled previously (19).
Selection for blaCTX-M genes is likely due to a combination of clonal expansion of
hosts carrying blaCTX-M and horizontal gene transfer of plasmids bearing bla-CTX-M. Our
results are consistent with epidemiological data on beta-lactam resistance genes (35,
36), which document the rapid spread of blaCTX-M genes worldwide to a “pandemic”
status. In this study, blaCTX-M genes were under stronger selection than a large diversity
of other resistance genes, possibly due to lower ﬁtness cost (either metabolic or due to
genetic context) and/or due to more efﬁcient degradation and a potential wider
degradative capacity. For example, previous research found that the MICs of blaCTX-M-
positive bacteria isolated from river sediment downstream of a wastewater treatment
plant were in excess of 2,048 g/ml (37). Additionally, many TEM and OXA beta-
lactamases do not have the extended-spectrum degradative capability of CTX-M ESBLs
(35, 36). We suggest that the ability of blaCTX-M genes to outcompete other beta-
lactamase genes at all studied concentrations may also have contributed to the
pandemic spread of blaCTX-M genes worldwide (35) and the replacement of other
beta-lactamase variants (36).
The metagenome analyses showed that ampC genes were detected but not en-
riched by cefotaxime exposure. Overexpression of chromosomal ampC genes can
increase levels of resistance to many antibiotics, including cefotaxime, but these genes
were very rare within metagenomes and confer only low-level resistance up to 8 mg/
liter (38), suggesting that they do not play a signiﬁcant role at the community level in
this study (39). The metagenome analyses also showed that cefotaxime can also
co-select for resistance to a range of antibiotic classes, even at subinhibitory cefotaxime
concentrations. Co-occurrence of blaCTX-M genes and aminoglycoside resistance has
been reported previously and is conﬁrmed here (36). High levels of co-selection also
indicate the presence of multidrug resistant plasmids, via co-resistance (i.e., co-
localization of multiple genes, of which only one needs to be under positive selection)
(40).
The bacterial community analyses showed that cefotaxime had signiﬁcant effects on
community structure, even at subinhibitory concentrations, through elimination of
several species as determined by LEfSe. The bacterial communities in all treatments
comprised mainly of Gram-negative bacterial families, with E. coli being the most
abundant species in all treatments. In wastewater, with a lower temperature and
different nutritional composition, interspecies competition with other taxa could result
in reduced E. coli abundance, which may be favored by the medium and temperature
used in this study. However, E. coli is known to survive wastewater treatment and is
used as a fecal indicator organism to assess water quality (41). Therefore, in wastewater,
E. coli may still possess a competitive advantage. There was much greater variability
between replicates (for all species other than E. coli) within exposed communities,
indicative of potential founder effects on evolution within individual microcosms, again
supporting the hypothesis that selection was acting at these concentrations. Worry-
ingly, cefotaxime exposure enriched for well-known opportunistic Gram-negative
pathogens, including P. aeruginosa, which readily infects immunocompromised indi-
viduals such as cystic ﬁbrosis patients, and A. baumannii, which is most commonly
associated with hospital-acquired infections (42). Enrichment for these opportunistic
pathogens and human and gut commensals such as B. fragilis and E. faecalis under
cefotaxime exposure may be due to intrinsic resistance, which is likely to result in
enrichment within communities including susceptible strains.
In summary, our ﬁndings develop understanding of selection for antibiotic resis-
tance by showing that the strength of selection for clinically important resistance genes
in a community context can be equal across a very large antibiotic concentration
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gradient; in other words, we show that the strength of selection within a given selective
space may be constant. Therefore, selection pressure below the MIC of susceptible
bacteria may be as strong as selection between the MICs of susceptible and resistant
bacteria (traditional selective window). We hypothesize that in our study, this obser-
vation is due to the community-wide beneﬁt provided by resistant bacteria harboring
degradative resistance mechanisms. Marked increases in common Gram-negative,
opportunistic pathogens and co-selection for resistance to other antibiotic classes raise
concerns about selection and co-selection for clinically relevant genes (such as
blaCTX-M) in pathogenic hosts occurring in a wide range of ecologic compartments.
MATERIALS AND METHODS
Complex community collection, storage, and preparation. Domestic sewage inﬂuent from a
wastewater treatment plant serving a small town was collected in October 2015. The treatment plant
serves a population of 43,000. Single-use aliquots were mixed in a 1:1 ratio with 20% glycerol, vortexed,
and stored at80°C. Before use, samples were spun down at 21,100 g for 10 min, the supernatant was
removed, and the pellet was resuspended twice in equal volumes of 0.85% NaCl to prevent nutrient/
chemical carryover.
A pilot experiment (data not shown) was conducted to determine the appropriate density of the
complex community inoculum by comparing growth over 24 h of different dilutions of inoculum at a
range of antibiotic concentrations in a 96-well plate. Following results from the pilot experiment, the 10%
(vol/vol) wastewater inoculum was used for all further experiments using the complex community on the
basis that it produced the tightest replicates at all the time points and the most reliable growth phases
over 24 h.
Selection experiments. Iso-Sensitest broth (Sigma) was inoculated with 10% (vol/vol) of untreated
wastewater. This was separated into 30-ml aliquots, and appropriate amounts of cefotaxime stock
solution were added. Cefotaxime (Molekular) stocks were prepared in autoclaved and ﬁltered (0.22-m)
deionized water.
These 30-ml aliquots were further separated into 5-ml aliquots, with 5 replicates for each of the
cefotaxime assay concentrations: 2 mg/liter, 1 mg/liter, and 500, 250, 125, 62.5, 31.25, 15.625, and
0 g/liter for the ﬁrst experiment and 128, 64, 32, 16, 8, 4, 2, and 0 mg/liter for the second experiment.
All replicates were immediately sampled for the day 0 sampling time point: 2 portions of 1 ml of each
replicate for each treatment were spun down at 21,100 g for 3 min, the supernatant was removed, and
pellet was resuspended in 1,000 l 20% glycerol followed by storage at80°C. All other samples for DNA
extraction were taken following each overnight incubation at 37°C, with 180-rpm shaking, as described
above.
After each incubation, 50 l of each microcosm was inoculated into 5 ml fresh medium with fresh
antibiotic, and samples were taken as described above for a total of 8 days. Remaining cell suspensions
were spun down and stored as described above at the end of each experiment.
Metagenome analyses. Three replicates were chosen at random from the no-antibiotic, 125 g/liter,
500 g/liter, and 2 mg/liter treatments to undergo shotgun metagenome sequencing on the MiSeq2 v2
platform at University of Exeter Sequencing Service (ESS).
DNA was extracted from 1 ml of frozen overnight culture using the Mo Bio extraction kit according
to the manufacturer’s instructions. DNA was cleaned and concentrated using AMPure beads. First, 2 l
of 20 mg/ml RNase A (Qiagen) was added to 50 l DNA and incubated for 10 min at 37°C. Fifty microliters
of AMPure beads was mixed with the DNA/RNase solution, mixed gently by pipetting, and incubated at
room temperature for 5 to 10 min. Following pulse centrifugation to collect droplets, tubes were placed
on a magnetic stand and left until all beads had precipitated to the side of the tube. Supernatant was
removed, and beads were washed two times with 300 l freshly prepared 80% ethanol. Beads were air
dried brieﬂy (1 to 2 min), resuspended in 10 l 10 mM Tris-HCl, and then incubated for another 10 min
at 50°C. Following pulse centrifugation and bead precipitation, DNA was transferred into a fresh tube and
stored at 20°C until library preparation and sequencing.
The 12 Nextera library preparations, quality control, sequencing, and primary sequencing analysis
(including trimming reads of the barcodes) were performed by ESS. Data were then run through the
ARGs-OAP (online analysis pipeline for antibiotic resistance genes detection from metagenome data
using an integrated structured antibiotic resistance gene database) (28). This provides the abundance of
different resistance gene classes and subtypes within these groups normalized by parts per million, 16S
rRNA copy number, and cell number. For all subsequent analysis, data normalized by 16S rRNA copy
number were used to be in accordance with the qPCR data generated. Heat maps for resistance gene
abundance were generated using pandas (43), Matplotlib (44), and Seaborn (45) Python packages for
resistance gene class and beta-lactam resistance gene subtype, for averages from these three replicates.
16S rRNA sequences were extracted from the Illumina sequencing data as follows: ﬁrst, forward and
reverse reads were adapter trimmed using Skewer (46) in paired-end mode. FastQC (47) and MultiQC (48)
veriﬁed successful adapter removal and that sequences were of acceptable quality before paired-end
reads were combined with FLASH version 2 (49) with the maximum overlap set to 300. 16S rRNA
sequences were extracted and assigned to bacterial species using MetaPhlAn2 (27). The resulting heat
map of species relative abundance was generated using HClust2 using Bray-Curtis distance measure-
ments between samples and features (species) (50), and overall species abundance across treatments
was visualized with GraPhlAn (51). Linear discriminant analysis (LDA) effect size (LEfSe) analyses were
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performed, and results were visualized with LEfSe (52) to identify which species, if any, were enriched by
a particular cefotaxime treatment.
qPCR analyses. Frozen samples were thawed, and DNA was extracted using the MBio UltraClean
DNA extraction kit according to instructions. DNA was diluted 5 to 10 before use.
The qPCR conditions were optimized using primers from previous studies (53, 54): 10 l Brilliant qPCR
SYBR green master mix, 2 l primer pair (5 M [each] forward and reverse primers for 16S rRNA, and
9 M [each] forward and reverse CTX-M primers), 0.2 l bovine serum albumin (BSA) (20 mg/ml), 0.4 l
ROX reference dye (20 M), 5 l diluted DNA template, and ﬁltered, sterilized water to a total volume
of 20 l. The qPCR program for all reactions was 95°C for 3 min, followed by 40 cycles of 95°C for 10 s
and 60°C for 30 s. blaCTX-M copy number was divided by 16S rRNA copy number to determine blaCTX-M
gene/16S rRNA, a proxy for blaCTX-M prevalence.
gBlock synthetic genes (Integrated DNA Technologies [Table 1]) were used as qPCR standards; these
were resuspended in Tris-EDTA (TE) buffer according to the manufacturer’s instructions and were stored
at 80°C.
Standards were 10 serially diluted in TE buffer and stored at20°C before use. Every PCR plate was
always run with 5 serial dilutions of standards in duplicate (and a duplicate negative control). Provided
that the efﬁciency for the reaction was between 90% and 110%, the average threshold cycle (CT) for the
duplicate technical replicates for each sample was used to calculate the copy number based on a “gold
standard” standard series, where the DNA concentration had been quantiﬁed by Qubit and the copy
number per microliter quantiﬁed immediately prior to cycling.
Data analyses. All statistics were performed in RStudio (55). Selection coefﬁcients were used to
determine MSC, with the following equation, as described previously (3): {ln[R(t)/R(0)]}/(t), where R is
resistance prevalence, t is time in days, and R(0) is resistance prevalence at time zero. The MSC is
estimated by the line of best-ﬁt x-axis intersect. Figures were generated with various Python packages
(43–45).
Chemical extraction/analyses. Complex community microcosms were sampled at the day 0 point
and after the ﬁrst 24 h. Antibiotic stocks were also quantiﬁed.
The extraction procedure was as follows: 400 l of culture was mixed with 400 l HiPerChromosolv
acetonitrile in a 2-ml 96-well plate and spun at 3,500 rpm for 30 min. One hundred microliters of this
supernatant was then mixed with 900 l of a 1:4 ratio of acetonitrile to high-pressure liquid chroma-
tography (HPLC)-grade water in a fresh plate and stored in the refrigerator. Antibiotic stocks were diluted
to a ﬁnal concentration of 100 ng/liter in 1:4 acetonitrile. Extraction mixtures were kept at 4°C until
processing.
Each concentration from the evolution experiment had a minimum of two chemical replicates from
at least two of the biological replicates. Stocks were single replicate only.
Antibiotic degradation experiment. Washed, untreated wastewater was diluted in 25-ml Iso-
Sensitest broth aliquots spiked with cefotaxime concentrations of 0, 15.625, 31.25, 62.5, 125, 250, and
500 g/liter or 2 mg/liter. A sterile control at the same concentrations was also prepared. These were
incubated at 37°C, with 180-rpm shaking in between samplings. Chemical extractions (see below) and
destructive sampling for optical density (OD) readings were performed at time zero and then every 3 h
for 24 h. OD measurements were carried out in a spectrophotometer (Jenway, United Kingdom) at the
same time points at 600 nm. Any samples with OD readings of a value greater than 1 were diluted 10
in Iso-Sensitest broth and then remeasured.
Supernatant experiment. E. coli strains J53 and NCTC 13451 were grown overnight at 37°C with
shaking at 180 rpm in Iso-Sensitest broth (supplemented with 2 mg/liter cefotaxime for NCTC 13451).
This concentration was chosen on the basis that it was greater than the J53 MIC (250 g/liter and
500 g/liter, determined by microdilution assay [56]), that it would be fully degraded in a beta-
lactamase-producing community (according to the overnight degradation experiment), and because it is
the clinical breakpoint concentration for Enterobacteriaceae (23). The supernatants from both overnight
cultures were spun down at 21,000  g for 2 min twice and then ﬁltered through a 0.22-m ﬁlter. J53
was inoculated at a starting optical density (600 nm) of 0.01 into fresh Iso-Sensitest broth amended with
2 mg/liter and J53 or NCTC 13451 supernatant (12.5% [vol/vol]). Controls included a blank control (to
check general aseptic technique), broth with each supernatant (to verify that the supernatant was sterile),
and J53 in broth both with and without antibiotic (to deduce effects of nutrient dilution).
TABLE 1 List of synthetic gene blocks used in the study, their DNA sequence, size in base pairs, and accession numbers used to for
design
Gene Sequence Size (bp) Accession no.
16S ACGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGGGAGTG
GGTTGCAAAAGAAGTAGGTAGCTTAACCTTCGGGAGGGCGCTTACCACTTTGTG
ATTCATGACTGGGGTGAAGTCGTAACAAGGTAACCG
144 CP018770.2
CTX-M GATGTGCAGCACCAGTAAAGTGATGGCCGCGGCCGCGGTGCTGAAGAAAAGTGA
AAGCGAACCGAATCTGTTAAATCAGCGAGTTGAGATCAAAAAATCTGACCTTGTTAA
CTATAATCCGATTGCGGAAAAGCACGTCAATGGGACGATGTCACTGGCTGAGCTTA
GCGCGGCCGCGCTACAGTACAGCGATAACGTGGCGATGAATAAGCTGATTGCTCACG
TTGGCGGCCCGGCTAGCGTCACCGCGTTCGCCCGACAGCTGGGAGACGAAACGTTCC
GTCTCGACCGTACCGAGCCGACGTTAAACACCGCCATTCCGGGCGATCCGCGTGATA
338 KX452391.1
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SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00969-18.
FIG S1, DOCX ﬁle, 0.3 MB.
FIG S2, DOCX ﬁle, 0.1 MB.
FIG S3, DOCX ﬁle, 0.1 MB.
FIG S4, DOCX ﬁle, 0.04 MB.
FIG S5, DOCX ﬁle, 0.04 MB.
FIG S6, DOCX ﬁle, 0.04 MB.
FIG S7, DOCX ﬁle, 0.05 MB.
FIG S8, DOCX ﬁle, 0.1 MB.
TABLE S1, DOCX ﬁle, 0.01 MB.
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